Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-1780 in Adult Chronic Kidney Disease
CTR20260587Phase 3Active
- Sponsor
- Shandong Sende
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-1780 in chronic kidney disease (CKD), sponsored by Shandong Sende. Started Mar 2026; status: active.
02
Drugs
HRS-1780
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20260587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260587.